Drug Manufacturers - Specialty & Generic stock research

Latest Sharemaestro market news for US Drug Manufacturers - Specialty & Generic stocks, compared with the broader Healthcare sector.

Drug Manufacturers - Specialty & GenericCoverage Weekly price dataMain comparison Price and signalsWhat we show

Featured analysis · Healthcare · VTRS

Viatris’ high-range grind stands out in a generic-drug group short on Trend Signals

VTRS finished the week at $17.56, just 2.8% below its 52-week high, with an active 49-week trend backdrop but only baseline volume confirmation.

Sharemaestro Research Desk 7 Aug 2026 3 min read

Read the analysis Interactive chart Full report

52-week price historyVTRS price · Trend Line · Fair Value

PriceTrendFair Value

Latest Close17.56 USD2026-07-311W Return1.9%latest completed week4W Return5.1%short-term follow-through12W Return3.0%quarterly tape

Current setup

Balanced readOverall score 67/100

Trend backdropActive

Activity pressureNo fresh buy

Price vs Trend16.8%

Volume1.0x

Latest company research

Latest analysis

Price action in context—what moved, what confirmed it, and what still needs proving.

RDY15.7%

Healthcare Drug Manufacturers - Specialty & Generic

Dr. Reddy’s volume-backed jump outruns generic-drug breadth, but Trend Signal stays off

The NYSE-listed ADR rose 15.7% on 19.8M shares, moving within 1.9% of its 52-week high, although Sharemaestro’s regime evidence remains only balanced.

1W Return15.7%4W Return12.8% Overall score56/100

NBIX6.5%

Healthcare Drug Manufacturers - Specialty & Generic

Neurocrine’s 28% quarter reaches the range top with only 1.1x volume

NBIX closed within 0.6% of its 52-week high after a 6.5% week, but participation was only modest and the Sharemaestro read remains balanced rather than decisive.

1W Return6.5%4W Return6.5% Overall score59/100